Blue Cross NC policies, page 10

Search Blue Cross NC's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

1,022 public policies Substrate tracks for Blue Cross NC, by title.

Blue Cross NC policies
PolicyDetailsCodesSource
Immunization GuidelinesCommercial34Original policy ↗
Immunization GuidelinesEffective Jun 1, 202219Original policy ↗
Immunohistochemistry AHS – P2018P2018 · Commercial3Original policy ↗
Immunohistochemistry AHS – P2018P2018 · Commercial5Original policy ↗
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies AHS - G2105G2105 · Commercial11Original policy ↗
Implantable Bone Conduction Hearing AidsCommercial21Original policy ↗
Implantable Cardioverter DefibrillatorCommercial47Original policy ↗
Important Change to Your Patients’ Specialty Prescriptions (PDF)NCBCBS-CR-078437-25-CPN78340-V3 · Commercial, Medicaid—Original policy ↗
Important Information About Specialty Prescriptions (PDF)NCBCBS-CR-072485-24-CPN72385 · Medicaid—Original policy ↗
Improving Patient Outcomes: Back to the Basics (PDF)NCBCBS-CR-069865-24-CPN69806 · Medicaid—Original policy ↗
In Vitro Chemoresistance and Chemosensitivity Assays AHS - G2100G2100 · Commercial11Original policy ↗
In Vitro Chemoresistance and Chemosensitivity Assays AHS- G2100AHS-G2100 · Commercial19Original policy ↗
Infertility Diagnosis and Treatment – B0006B0006 · Commercial108Original policy ↗
Infusion Therapy in the HomeCommercial102Original policy ↗
Injectable Bulking Agents for the Treatment of Urinary and Fecal IncontinenceCommercial34Original policy ↗
Injection Therapy for Headache (Migraine and Other) and Non-Spine ManagementCommercial16Original policy ↗
Inpatient Interfacility TransfersCommercial—Original policy ↗
Inpatient ReadmissionsCommercial—Original policy ↗
Inpatient ReadmissionsEffective Jul 1, 2025 · Commercial—Original policy ↗
Inpatient ReadmissionsMedicaid—Original policy ↗
Inpatient Readmissions—Original policy ↗
Inpatient Readmissions (PDF)G-13001 · Medicaid—Original policy ↗
Insulin Therapy, Chronic Intermittent Intravenous (CIIIT)Commercial1Original policy ↗
Intensity Modulated Radiation Therapy (IMRT) for Sarcoma of the ExtremitiesCommercial8Original policy ↗
Intensity Modulated Radiation Therapy (IMRT) of Abdomen and PelvisCommercial10Original policy ↗
Intensity Modulated Radiation Therapy (IMRT) of Head and NeckCommercial10Original policy ↗
Intensity Modulated Radiation Therapy (IMRT) of the ChestCommercial10Original policy ↗
Intensity Modulated Radiation Therapy (IMRT) of the ProstateCommercial12Original policy ↗
Intensity Modulated Radiation Therapy for Tumors of the Central Nervous SystemCommercial10Original policy ↗
Intensity Modulated Radiation Therapy for Tumors of the Central Nervous System "NOTIFICATION"Commercial8Original policy ↗
Intensive Outpatient Program (IOP) Behavioral Health56Original policy ↗
Interfacility TransferCommercial—Original policy ↗
Interfacility TransferCommercial—Original policy ↗
Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)Commercial8Original policy ↗
Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)Medicaid6Original policy ↗
Interspinous Fixation (Fusion) DevicesCommercial4Original policy ↗
Intracellular Micronutrient Analysis AHS – G2099G2099 · Commercial27Original policy ↗
Intradialytic Parenteral NutritionCommercial23Original policy ↗
Intraoperative Neurophysiologic MonitoringCommercial25Original policy ↗
Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric DisordersCommercial5Original policy ↗
Intravenous Antibiotic Therapy for Lyme DiseaseCommercial15Original policy ↗
Investigational (Experimental) ServicesCommercial2Original policy ↗
Investigational (Experimental) ServicesMedicaid—Original policy ↗
IR Opioid QL Criteria (PDF)Commercial—Original policy ↗
Islet Cell TransplantationCommercial16Original policy ↗
JAK2, CALR, or MPL Mutation Analysis in Myeloproliferative Neoplasms AHS - M2101M2101 · Commercial8Original policy ↗
KeratoprosthesisCommercial3Original policy ↗
Kroger Specialty Pharmacy Acquisition (PDF)NCBCBS-CR-072476-24-CPN72372 · Medicaid—Original policy ↗
Laboratory Procedures Medical Policy AHS - R2162AHS - R2162 · Commercial93Original policy ↗
Laboratory Procedures Medical Policy AHS - R2162 NotificationAHS - R2162 · Commercial84Original policy ↗

Back to Blue Cross NC · Blue Cross NC prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.